Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Juva Life Inc C.JUVA

Alternate Symbol(s):  JUVAF

Juva Life Inc. is a Canada-based life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. The principal business of the Company is to acquire, own, and operate various cannabis businesses in the state of California. Its segments include the resale of merchandise and cannabis derived products, and cultivation and sale of trim and flowers. The Company is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and recreational cannabis users. Juva Retail is a network of retail cannabis facilities that serves the San Francisco Bay Area and other areas. It leverages revenue derived from its retail operations to advance JUVA-019, JUVA-041, and other potentially valuable non-cannabinoid bio actives for consumer and pharma product applications.


CSE:JUVA - Post by User

Comment by SpaceLabson Mar 01, 2022 11:07am
65 Views
Post# 34471153

RE:Arbitrage

RE:ArbitrageHave you tried any of that to see if it works or not M1234?

Seems like a HOAX by Doug Chlopeek. to raise more funds from Canadians again?



Matteo1234 wrote: Big boys stealing your shares in a illiquid stock. Stayhard...The news follows the Company’s identification of non-cannabinoid compound JUVA-019, on which the Company has filed a patent application and has conducted preclinical research showing that the compound is effective as a stand-alone compound in inhibiting inflammation by modulating certain biomarkers in the body. Through its research division, Juva scientists have continuously been evaluating an internally curated database of compounds found in the cannabis plant for their therapeutic benefit, leading to the identification of the two proprietary compounds: JUVA-019 and JUVA-041, which the Company has nominated as drug candidates for further pre-clinical investigation. Current efforts are focused on advancing both compounds through phenotypic models of chronic diseases of aging.


<< Previous
Bullboard Posts
Next >>